Perrigo (PRGO) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $16.63, +0.91% vs the prior close of $16.48.
- Volume 2.44M shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
PRGO rises 0.9% to $16.63, a 6-month high, 3 up days in a row. Closed at $16.63, +0.91% vs the prior close of $16.48. Day range $16.26–$16.68, opened at $16.54.
PRGO daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — PRGO rises 0.9% to $16.63, a 6-month high, 3 up days in a row
- Closed at $16.63, +0.91% vs the prior close of $16.48. Day range $16.26–$16.68, opened at $16.54.
- Volume was 2.44M shares, 0.9x its 50-day average of 2.71M.
- Price is +16.8% vs its 50-day average ($14.23) and +34.4% vs its 200-day average ($12.37).
- 52-week range $9.23–$22.02; today's close sits at 58% of that range, 24.5% below the 52-week high.
- That makes 3 straight gains.
Oct 15, 2026 — PRGO jumps 3.3% to $16.48, a 6-month high
- Closed at $16.48, +3.32% vs the prior close of $15.95. Day range $16.08–$16.66, opened at $16.16.
- Volume was 3.31M shares, 1.2x its 50-day average of 2.81M.
- Price is +16.5% vs its 50-day average ($14.15) and +33.3% vs its 200-day average ($12.36).
- 52-week range $9.23–$22.02; today's close sits at 57% of that range, 25.2% below the 52-week high.
Oct 14, 2026 — PRGO jumps 3.8% to $15.95, a 6-month high
- Closed at $15.95, +3.77% vs the prior close of $15.37. Day range $15.13–$16.17, opened at $15.29.
- Volume was 4.64M shares, 1.7x its 50-day average of 2.77M.
- Price is +13.2% vs its 50-day average ($14.09) and +29.2% vs its 200-day average ($12.35).
- 52-week range $9.23–$22.02; today's close sits at 53% of that range, 27.6% below the 52-week high.
Oct 13, 2026 — PRGO dips 0.5% to $15.37
- Closed at $15.37, -0.52% vs the prior close of $15.45. Day range $15.19–$15.73, opened at $15.19.
- Volume was 1.76M shares, 0.6x its 50-day average of 2.80M.
- Price is +9.9% vs its 50-day average ($13.98) and +24.6% vs its 200-day average ($12.34).
- 52-week range $9.23–$22.02; today's close sits at 48% of that range, 30.2% below the 52-week high.
Oct 12, 2026 — PRGO rises 2.6% to $15.45, a 6-month high
- Closed at $15.45, +2.59% vs the prior close of $15.06. Day range $14.86–$15.52, opened at $14.90.
- Volume was 1.84M shares, 0.7x its 50-day average of 2.83M.
- Price is +11.2% vs its 50-day average ($13.89) and +25.3% vs its 200-day average ($12.33).
- 52-week range $9.23–$22.02; today's close sits at 49% of that range, 29.8% below the 52-week high.
Oct 9, 2026 — PRGO jumps 3.9% to $15.06
- Closed at $15.06, +3.86% vs the prior close of $14.50. Day range $14.24–$15.52, opened at $14.24.
- Volume was 4.40M shares, 1.6x its 50-day average of 2.79M.
- Price is +9.3% vs its 50-day average ($13.78) and +22.2% vs its 200-day average ($12.32).
- 52-week range $9.23–$22.02; today's close sits at 46% of that range, 31.6% below the 52-week high.
Oct 8, 2026 — PRGO dips 0.3% to $14.50
- Closed at $14.50, -0.34% vs the prior close of $14.55. Day range $14.10–$14.56, opened at $14.45.
- Volume was 2.88M shares, 1.0x its 50-day average of 2.81M.
- Price is +5.9% vs its 50-day average ($13.69) and +17.8% vs its 200-day average ($12.31).
- 52-week range $9.23–$22.02; today's close sits at 41% of that range, 34.2% below the 52-week high.
Oct 7, 2026 — PRGO jumps 3.9% to $14.55
- Closed at $14.55, +3.93% vs the prior close of $14.00. Day range $14.00–$14.62, opened at $14.00.
- Volume was 1.91M shares, 0.7x its 50-day average of 2.83M.
- Price is +6.9% vs its 50-day average ($13.61) and +18.2% vs its 200-day average ($12.31).
- 52-week range $9.23–$22.21; today's close sits at 41% of that range, 34.5% below the 52-week high.
Oct 6, 2026 — PRGO slides 3.0% to $14.00
- Closed at $14.00, -3.05% vs the prior close of $14.44. Day range $13.91–$14.63, opened at $14.57.
- Volume was 2.04M shares, 0.7x its 50-day average of 2.85M.
- Price is +3.5% vs its 50-day average ($13.52) and +13.8% vs its 200-day average ($12.30).
- 52-week range $9.23–$22.48; today's close sits at 36% of that range, 37.7% below the 52-week high.
Oct 5, 2026 — PRGO rises 1.3% to $14.44
- Closed at $14.44, +1.26% vs the prior close of $14.26. Day range $14.02–$14.58, opened at $14.20.
- Volume was 1.88M shares, 0.7x its 50-day average of 2.86M.
- Price is +7.4% vs its 50-day average ($13.44) and +17.4% vs its 200-day average ($12.30).
- 52-week range $9.23–$22.65; today's close sits at 39% of that range, 36.2% below the 52-week high.
Oct 2, 2026 — PRGO rises 1.7% to $14.26
- Closed at $14.26, +1.71% vs the prior close of $14.02. Day range $14.12–$14.80, opened at $14.18.
- Volume was 2.17M shares, 0.8x its 50-day average of 2.88M.
- Price is +6.8% vs its 50-day average ($13.36) and +16.0% vs its 200-day average ($12.29).
- 52-week range $9.23–$22.65; today's close sits at 37% of that range, 37.0% below the 52-week high.
PRGO latest news & SEC filings
Every SEC filing by or about PRGO in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 8, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 5, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 27, 2026:
- Revenue: $1.02B (prior year $1.06B) (-3.2% vs Jun 28, 2025)
- Net income: $74.50M (prior year -$8.40M) (swung to profit vs Jun 28, 2025)
- Diluted EPS: $0.53 (prior year -$0.06) (swung to profit vs Jun 28, 2025)
Aug 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 29, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 23, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 6, 2026 · Form 8-K/A — Current report (amended)
Amended current report
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jul 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jun 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jun 24, 2026 · Form 11-K — Annual report for an employee stock plan
Annual report for an employee stock plan
Things to know before you trade PRGO
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Apr 22, 2026, Feb 26, 2026. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.72% (largest 6.1%).
- Liquidity: about 2.87M shares (≈$47.74M) trade per day on average.
- 52-week position: $16.63 vs a range of $9.23–$22.02 (58% of the range).
- Dividends: last ex-dividend date Aug 28, 2026 ($0.29/share); 3 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 0 sales; latest: Geoffrey M. Parker bought 7,500 shares on Nov 12, 2025.
- Latest filings: 10-Q Aug 5, 2026; 8-K Aug 5, 2026; 8-K Jul 6, 2026.
- Share count: 138.77M shares outstanding (Jul 31, 2026), +0.9% vs a year earlier.
- Listing: NYSE · industry: Pharmaceutical Preparations.
PRGO market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 16.54 | 16.68 | 16.26 | 16.63 | 2.44M |
| Oct 15, 2026 | 16.16 | 16.66 | 16.08 | 16.48 | 3.31M |
| Oct 14, 2026 | 15.29 | 16.17 | 15.13 | 15.95 | 4.64M |
| Oct 13, 2026 | 15.19 | 15.73 | 15.19 | 15.37 | 1.76M |
| Oct 12, 2026 | 14.90 | 15.52 | 14.86 | 15.45 | 1.84M |
| Oct 9, 2026 | 14.24 | 15.52 | 14.24 | 15.06 | 4.40M |
| Oct 8, 2026 | 14.45 | 14.56 | 14.10 | 14.50 | 2.88M |
| Oct 7, 2026 | 14.00 | 14.62 | 14.00 | 14.55 | 1.91M |
| Oct 6, 2026 | 14.57 | 14.63 | 13.91 | 14.00 | 2.04M |
| Oct 5, 2026 | 14.20 | 14.58 | 14.02 | 14.44 | 1.88M |
| Oct 2, 2026 | 14.18 | 14.80 | 14.12 | 14.26 | 2.17M |
| Oct 1, 2026 | 14.72 | 14.87 | 14.02 | 14.02 | 2.64M |
| Sep 30, 2026 | 15.07 | 15.14 | 14.73 | 14.76 | 2.55M |
| Sep 29, 2026 | 15.13 | 15.20 | 14.84 | 15.00 | 2.60M |
| Sep 28, 2026 | 15.21 | 15.43 | 14.90 | 15.10 | 2.89M |
| Sep 25, 2026 | 14.81 | 15.69 | 14.22 | 15.42 | 4.27M |
| Sep 24, 2026 | 13.87 | 15.10 | 13.84 | 14.68 | 7.73M |
| Sep 23, 2026 | 14.22 | 14.46 | 13.76 | 13.84 | 1.46M |
| Sep 22, 2026 | 14.20 | 14.45 | 14.16 | 14.31 | 2.32M |
| Sep 21, 2026 | 14.00 | 14.22 | 13.61 | 14.13 | 1.71M |
About Perrigo
Perrigo (PRGO) is listed on the NYSE and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in DUBLIN 2, Ireland. State of incorporation: Ireland. Fiscal year ends December 31. SEC CIK 1585364.
PRGO board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Orlando D Ashford | Director | May 15, 2026 |
| Bradley A Alford | Director | Sep 15, 2026 |
| Ahmed Salman Amin | Director | Jul 15, 2026 |
| Julia M Brown | Director | May 15, 2026 |
| Kevin Francis Egan | Director | May 15, 2026 |
| Muhammad Omer Gajial | Director | Jul 15, 2026 |
| Albert Manzone | Interim President and CEO | Jul 23, 2026 |
| Donal O'Connor | Director | May 15, 2026 |
| Geoffrey M. Parker | Director | Sep 15, 2026 |
| Jonas Samuelson | Director | May 15, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Charles Atkinson | EVP, General Counsel & Sec. | Jul 10, 2026 |
| David Ball | EVP & CBDO | Sep 10, 2026 |
| Eduardo Guarita Bezerra | EVP & Chief Financial Officer | Jul 10, 2026 |
| Roberto Khoury | EVP and President of CSCI | Jul 10, 2026 |
| Abigail Lennox | EVP and CSO | Jul 10, 2026 |
| Albert Manzone | Interim President and CEO | Jul 23, 2026 |
| Robert Willis | EVP & CHRO | Jul 10, 2026 |
| Matthew John Winterman | EVP, Supply, Ops, Strategy | Jul 10, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Nov 12, 2025 | Geoffrey M. Parker | Buy | 7,500 | $14.18 |
| Nov 12, 2025 | Geoffrey M. Parker | Buy | 7,500 | $14.18 |
| Nov 12, 2025 | Geoffrey M. Parker | Buy | 7,500 | $14.18 |
| Nov 12, 2025 | Geoffrey M. Parker | Buy | 7,500 | $14.18 |
PRGO financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $4.25B | $-1.43B | -10.29 | $238.50M |
| Dec 31, 2024 | $4.37B | $-171.80M | -1.25 | $362.90M |
| Dec 31, 2023 | $4.66B | $-12.70M | -0.09 | $405.50M |
| Dec 31, 2022 | $4.45B | $-140.60M | -1.04 | $307.30M |
| Dec 31, 2021 | $4.14B | $-68.90M | -0.52 | $156.30M |
Latest balance sheet: total assets $7.61B, total liabilities $5.09B, cash $432.10M (as of Jun 27, 2026).
PRGO earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $13.27 |
| May 6, 2026 | 8-K Item 2.02 (results) | $12.26 |
| Apr 22, 2026 | 8-K Item 2.02 (results) | $11.82 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $14.19 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $15.10 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $23.61 |
| May 7, 2025 | 8-K Item 2.02 (results) | $26.41 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $24.13 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $27.31 |
| Aug 2, 2024 | 8-K Item 2.02 (results) | — |
| May 7, 2024 | 8-K Item 2.02 (results) | — |
| Feb 27, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on PRGO
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.